Fox, S., Generali, D., Berruti, A., Brizzi, M., Campo, L., Bonardi, S., . . . Harris, A. (2011). The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen.
توثيق أسلوب شيكاغو (الطبعة السابعة عشر)Fox, S., et al. The Prolyl Hydroxylase Enzymes Are Positively Associated with Hypoxia-inducible Factor-1α and Vascular Endothelial Growth Factor in Human Breast Cancer and Alter in Response to Primary Systemic Treatment with Epirubicin and Tamoxifen. 2011.
توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)Fox, S., et al. The Prolyl Hydroxylase Enzymes Are Positively Associated with Hypoxia-inducible Factor-1α and Vascular Endothelial Growth Factor in Human Breast Cancer and Alter in Response to Primary Systemic Treatment with Epirubicin and Tamoxifen. 2011.